Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Medrego | Gene & Stem Cell Therapy Innovations logo — Gene & Stem Cell Therapy Innovations | Manufacturing & Exper...

Medrego | Gene & Stem Cell Therapy Innovations

Gene & Stem Cell Therapy Innovations | Manufacturing & Expertise | CAR T cell | For Greater Humanity!

Founded 2017 Latvia Latvia 3 employees Biotechnology, Life Sciences

General Information

Company Name Medrego | Gene & Stem Cell Therapy Innovations
Founded Year 2017
Location Latvia Latvia +2
Employees 3
Industries Biotechnology, Life Sciences
Social

Get notified when Medrego | Gene & Stem Cell Therapy Innovations moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Medrego | Gene & Stem Cell Therapy Innovations

Medrego is a biotechnology startup based in Latvia, founded in 2017. The company specializes in Gene & Stem Cell Therapy Innovations and offers expertise in CAR T-cell therapies, Gene Therapies, Stem Cell Therapies, and ATMP product development and regulatory frameworks. The team boasts extensive experience, including involvement in European Medicines Agency (EMA) committees, participation in EU project R&D activities, and consulting for organizations such as KPMG and Voisin Consulting. Medrego is positioning itself as a key player in the advancement of therapies for the betterment of humanity. With its extensive network and expertise, the company is well-poised to make significant contributions to the Life Science world. However, details about their funding, investors, and recent investment activities are currently unavailable. Despite this, Medrego's unique focus and experienced team present an intriguing opportunity for potential investors looking to support pioneering advancements in biotechnology.

Taxonomy: Gene Therapy, Stem Cell Therapy, CAR T-cell, ATMP Product Development, Regulatory Frameworks, European Medicines Agency (EMA), Cell Product Working Party (CPWP), R&D, Medical Consultations, Life Science, Biotech Innovations, Expertise, Medrego Biotech, Advisory

No funding data available for Medrego | Gene & Stem Cell Therapy Innovations yet.

Get notified when Medrego | Gene & Stem Cell Therapy Innovations raises funding

Medrego | Gene & Stem Cell Therapy Innovations Alternatives & Competitors

Medrego | Gene & Stem Cell Therapy Innovations vs
Notch Therapeutics
Notch Therapeutics Canada

Notch is working to maximize the benefit of cell therapies through a proprietary T cell-production p...

Series A
9 employees
Biotechnology
Medrego | Gene & Stem Cell Therapy Innovations vs
Cell BioEngines, Inc
Cell BioEngines, Inc United States

‘Off-the-Shelf’ Curative Cell Therapies

Pre Seed
3 employees
Biotechnology, Health and Wellness
Medrego | Gene & Stem Cell Therapy Innovations vs
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd Singapore

A clinical-stage biotech company developing autologous and allogeneic cell therapies for the treatme...

Grant
47 employees
Biotechnology, Health Care

FAQ About Medrego | Gene & Stem Cell Therapy Innovations

Gene & Stem Cell Therapy Innovations | Manufacturing & Expertise | CAR T cell | For Greater Humanity!
Medrego | Gene & Stem Cell Therapy Innovations was founded in 2017.
Medrego | Gene & Stem Cell Therapy Innovations is headquartered in Latvia.
Medrego | Gene & Stem Cell Therapy Innovations operates in the following industries: Biotechnology, Life Sciences.
Medrego | Gene & Stem Cell Therapy Innovations has approximately 3 employees.
Top alternatives and competitors to Medrego | Gene & Stem Cell Therapy Innovations include Notch Therapeutics, Cell BioEngines, Inc, Tessa Therapeutics Ltd, Immix Biopharma (Nasdaq: IMMX), Emmecell. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medrego | Gene & Stem Cell Therapy Innovations and Notch Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Medrego | Gene & Stem Cell Therapy Innovations and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy